Treatment of AD model Tg2576 mice with nilotinib reduces c-Abl phosphorylation/activation and enhances autophagy, leading to a reduction in Aβ levels and preventing degeneration of dopaminergic neurons [2]. The gene discussed is ABL1; the disease is Alzheimer disease.